Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable ...

Vir Biotechnology (VIR) has signed a collaboration and license agreement with Gilead focused on three PRO-XTEN dual-masked ...

Nautilus Biotechnology, Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $0.2 ...

Vir Biotechnology is approaching multiple clinical readouts from drugs with positive data previously. Click here to read an ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the U.S. and European biopharma ...

Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...

The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...

The latest update cuts the fair value price target for PDS Biotechnology from US$5.75 to US$4.75, signaling a more conservative valuation anchor for the stock. Analysts link this change to a mix of ...

Nautilus Biotechnology (NAUT) is scheduled to announce Q3 earnings results on Tuesday, October 27th, before market open. The ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...